FDA Drug Shortage Database
Dopamine (Intropin) shortage
The FDA Drug Shortage Database lists 3 of 11 dopamine presentations as limited or unavailable (updated October 2, 2026); the first entry was posted on November 6, 2017. 8 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5% injection | 1 | 6 | 0 |
| 40mg/1ml injection | 2 | 0 | 0 |
| 200mg/5ml injection | 0 | 1 | 0 |
| 400mg/10ml injection | 0 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Hospira, Inc., a Pfizer Company | Current posted November 6, 2017, updated September 22, 2026 | Unavailable; Other |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | Current posted November 6, 2017, updated September 18, 2026 | Unavailable; Demand increase for the drug |
| Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | Current posted November 6, 2017, updated September 18, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (8)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Baxter Healthcare | Current posted November 6, 2017, updated October 2, 2026 | Available |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Baxter Healthcare | Current posted November 6, 2017, updated October 2, 2026 | Available |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Hospira, Inc., a Pfizer Company | Current posted November 6, 2017, updated September 22, 2026 | Available |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Baxter Healthcare | Current posted November 6, 2017, updated October 2, 2026 | Available |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Baxter Healthcare | Current posted November 6, 2017, updated October 2, 2026 | Available |
| Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Hospira, Inc., a Pfizer Company | Current posted November 6, 2017, updated September 22, 2026 | Available |
| Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | Current posted November 6, 2017, updated September 22, 2026 | Available |
| Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) | Hospira, Inc., a Pfizer Company | Current posted November 6, 2017, updated September 22, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage